Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GRBK | CLBT |
|---|---|---|
| Price | $65.47 | $11.20 |
| Change today | ▼ 1.79% | ▲ 1.17% |
| Market cap | $2.82B | $2.82B |
| Return, 3 months | -12.5% | -32.4% |
| Return, year to date | +4.5% | -37.9% |
| Return, 1 year | -11.9% | -40.4% |
| P/E (TTM) | 9.9 | 48.7 |
| P/B | 1.5 | 5.2 |
| P/E percentile vs own 5y | 84th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +18.6% |
| Net profit growth (YoY) | – | +127.7% |
| Gross margin | – | 84.2% |
| Operating margin | – | 14.0% |
| Net margin | – | 16.4% |
| Return on equity | – | 19.0% |
| Analyst target vs. price | – | +45.5% |
| Analyst buy share | – | 100% |
| RSI (14) | 38 | 44 |
| 30-day volatility | 21.7% | 40.9% |
| Max drawdown, 1 year | -24.0% | -46.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
